Frontlight ResearchEarly access
Trial site
Centro de Pesquisa Clínica do Brasil
- 7running trials
- 3closed trials
The trials here
What the 10 trials at this site are about, from their registry records.
- Conditions
- Obesity5 trials
- Type 2 diabetes4 trials
- Chronic kidney disease1 trial
- Coronary artery disease1 trial
- Fatty liver disease (MASLD/MASH)1 trial
- High blood pressure1 trial
- IgA nephropathy1 trial
- Prostate cancer1 trial
- Stroke1 trial
- Type 1 diabetes1 trial
- Phase
- Phase 39 trials
- Status
- Active, not recruiting4 trials
- Completed3 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- Eli Lilly and Company6 trials
- Amgen1 trial
- Boehringer Ingelheim1 trial
- McMaster University1 trial
- Novartis Pharmaceuticals1 trial
Running trials
Not yet recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
A Study for Cardiovascular and Lifestyle Risk Factors in Prostate Cancer Patients
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Type 2 diabetes2 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- High blood pressure1 recruiting
- Obesity1 recruiting
Closed trials
Completed
A Study of Orforglipron in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Completed
Completed
Site data: ClinicalTrials.govUpdated 19 Nov 2026